4.8 Letter

A methodological framework to enhance the clinical success of cancer immunotherapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

Immune parameters affecting the efficacy of chemotherapeutic regimens

Laurence Zitvogel et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2011)

Article Medicine, General & Internal

Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

Caroline Robert et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Review Multidisciplinary Sciences

Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion

Robert D. Schreiber et al.

SCIENCE (2011)

Review Oncology

Improved Endpoints for Cancer Immunotherapy Trials

Axel Hoos et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)

Article Medicine, General & Internal

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

F. Stephen Hodi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Medicine, General & Internal

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.

Philip W. Kantoff et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Letter Immunology

MIATA-Minimal Information about T Cell Assays

Sylvia Janetzki et al.

IMMUNITY (2009)

Article Biotechnology & Applied Microbiology

The cancer vaccine roller coaster

Bruce Goldman et al.

NATURE BIOTECHNOLOGY (2009)

Article Biotechnology & Applied Microbiology

Promoting coherent minimum reporting guidelines for biological and biomedical investigations:: the MIBBI project

Chris F. Taylor et al.

NATURE BIOTECHNOLOGY (2008)

Review Medicine, General & Internal

Molecular origins of cancer - Cancer immunology

Olivera J. Finn

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Review Oncology

A clinical development paradigm for cancer vaccines and related biologics

Axel Hoos et al.

JOURNAL OF IMMUNOTHERAPY (2007)